Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Annual Reports

Annual Report
FY 2022-23

View the interactive version of our current annual report

Annual Report
FY 2021-22

Annual Report
FY 2020-21

Annual Report
FY 2019-20

Annual Report
FY 2018-19

Annual Report
FY 2017-18

Annual Report
FY 2016-17

Annual Report
FY 2015-16

Investor Fact Sheet

Financial Information

ESG Reports

Syngene Expects Biz to Pick Up by H2 on Funding Revival
Syngene announces second year of STEM scholarship and mentorship program for women in collaboration with RICH

Investor Calendar

Conference Call For Analysts And Investors

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details